Cargando…
Effects of enzyme replacement therapy for cardiac-type Fabry patients with a Chinese hotspot late-onset Fabry mutation (IVS4+919G>A)
OBJECTIVE: Current studies of newborn screening for Fabry disease in Taiwan have revealed a remarkably high prevalence of cardiac-type Fabry disease with a Chinese hotspot late-onset Fabry mutation (IVS4+919G>A). DESIGN: Retrospective cohort study. SETTING: Tertiary medical centre. PARTICIPANTS:...
Autores principales: | Lin, Hsiang-Yu, Liu, Hao-Chuan, Huang, Yu-Hsiu, Liao, Hsuan-Chieh, Hsu, Ting-Rong, Shen, Chia-I, Li, Shao-Tzu, Li, Cheng-Fang, Lee, Li-Hong, Lee, Pi-Chang, Huang, Chun-Kai, Chiang, Chuan-Chi, Lin, Ching-Yuang, Lin, Shuan-Pei, Niu, Dau-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717460/ https://www.ncbi.nlm.nih.gov/pubmed/23864212 http://dx.doi.org/10.1136/bmjopen-2013-003146 |
Ejemplares similares
-
Endomyocardial biopsies in patients with left ventricular hypertrophy and a common Chinese later-onset fabry mutation (IVS4 + 919G > A)
por: Hsu, Ting-Rong, et al.
Publicado: (2014) -
Globotriaosylsphingosine (lyso-Gb3) might not be a reliable marker for monitoring the long-term therapeutic outcomes of enzyme replacement therapy for late-onset Fabry patients with the Chinese hotspot mutation (IVS4+919G>A)
por: Liu, Hao-Chuan, et al.
Publicado: (2014) -
Modulation the alternative splicing of GLA (IVS4+919G>A) in Fabry disease
por: Chang, Wen-Hsin, et al.
Publicado: (2017) -
Interleukin-18 deteriorates Fabry cardiomyopathy and contributes to the development of left ventricular hypertrophy in Fabry patients with GLA IVS4+919 G>A mutation
por: Chien, Yueh, et al.
Publicado: (2016) -
Correlations between Endomyocardial Biopsies and Cardiac Manifestations in Taiwanese Patients with the Chinese Hotspot IVS4+919G>A Mutation: Data from the Fabry Outcome Survey
por: Hsu, Ting-Rong, et al.
Publicado: (2017)